WIPO trademark

GALXC PLUS

MixedWIPOClass 5Class 42

"GALXC PLUS" is a trademark owned by Dicerna Pharmaceuticals, Inc., filed at the WIPO on July 14, 2021. It is on file and covers classes 5 and 42.

View Dicerna Pharmaceuticals, Inc. portfolioGet this data via the API
GALXC PLUS
Trademark as filed with the WIPO
Status
Mixed
Filed
July 14, 2021
Registered
Not yet
Expires
July 14, 2031
Application no.
Not recorded
Registration no.
1610784
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns GALXC PLUS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Dicerna Pharmaceuticals, Inc.

55 trademarks in the portfolioView company

Representative

Bridget H. Labutta Panitch Schwarze

Goods and services

What the mark covers

The products and services GALXC PLUS is filed for, grouped by Nice class.

  • Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; oligonucleotide compounds for use in the targeted delivery of RNAi therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies.

  • Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of disorders outside the liver; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections.

FAQ

About GALXC PLUS

Who owns the trademark "GALXC PLUS"?

The WIPO trademark "GALXC PLUS" is owned by Dicerna Pharmaceuticals, Inc.

What is the status of "GALXC PLUS"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GALXC PLUS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_31af5206-1b6e-420a-931c-2190fa3ea779
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_31af5206-1b6e-420a-931c-2190fa3ea779",
  "object": "trademark",
  "mark_text": "GALXC PLUS",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2021-07-14",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Dicerna Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbd3-862f-711a-8bfe-d2b68aad05fd"
    }
  ]
}